Recent Medicine releases

Cardioline S.p.A. hires Brian Brenegan as CEO

[PRESSWIRE] Italy – 9 November, 2018 -- Cardioline S.p.A. is pleased to announce the addition of Brian Brenegan as its Chief Executive Officer. 

The dark side of the hottest summer in a century: ‘The high rate of skin cancer among outdoor workers can be expected to increase still further’

[PRESSWIRE] Paris - September 12, 2018 -- The sun is one of the most dangerous carcinogens, yet people who work outdoors are inadequately protected. Since 2014, data on the UV exposure of outdoor workers (such as farmers, road workers, seasonal harvest workers, building workers, roofers, etc.) have been collected in Germany as part of the GENESIS-UV project – with alarming results.

HPV VACCINATION: Why does the door to a splendid future still remain closed?

[PRESSWIRE] Paris - September 12, 2018 -- HPV genital infections are the most frequent sexually transmitted infections of viral origin and definitely represent a global burden with significant oncogenic potential. HPV infection causes external genital warts, and some HPV types are strongly associated with cancer or precancerous lesions. HPV induced cancers are mostly (but not only!) those of the ano-genital region, such as cervical, anal, vulvar, penile cancer, etc., but the cancers of the mouth and/or throat are also included.

Dangers of tattoos – even the new ECHA proposals are not enough to guarantee safe inks!

[PRESSWIRE] Paris - September 12, 2018 -- Tattooing has gained tremendous popularity in Western countries. In Australia, Finland France and Germany, approximately 10% of the populations have at least one tattoo [1]. The ‘tattoo craze’ is particularly strong among the young generation, in which every third or fourth person has a tattoo.

ECHT-EVAL 2018 – the German project implementing the WHO ‘Global Report on Psoriasis’

[PRESSWIRE] Paris - September 12, 2018 -- Psoriasis is a chronic, non-communicable skin disease characterized by bright, silvery-white scales on reddened (inflamed) patches of skin, mainly on the arms and legs, the scalp, but also on many other areas of the body, including the genitals.

Caffeine consumption might extend life expectancy in CKD patients

[PRESSWIRE] Parma - 12 September, 2018 -- A study, which has been published in NDT [1] today shows that caffeine consumption is associated with a lower mortality rate in CKD patients. This relationship has already been observed in the general population. Although this study shows that this association may persist if caffeine is consumed through caffeine-containing soft drinks, the president of the European Renal Nutrition Working Group, Professor Denis Fouque, recommends CKD patients not to consume these soft drinks, but to drink coffee or tea instead.

Pre-dialysis blood pressure measurements misclassify hypertension in about 1/3 of hemodialysis patients

[PRESSWIRE] Parma  - 06 August, 2018 -- New NDT study [1] shows that `normal´ pre-dialysis blood pressure measurement is not reliable. “Without performing extended ambulatory BP recordings (44h - 48h) we approvingly accept an error rate of about 30% in the diagnosis of hypertension in dialysis patients, a highly vulnerable patient group with a dramatically elevated cardiovascular risk. This is why EURECA-m recommends ambulatory blood pressure monitoring as gold standard for the diagnosis for hypertension in hemodialysis patient."

ERA-EDTA and the Japanese Society of Nephrology build on firm foundations to improve treatment for kidney patients

[PRESSWIRE] Parma - 29 June, 2018 -- The ERA-EDTA and the Japanese Society of Nephrology (JSN) are delighted to announce continuing progress in their joint collaboration in the important field of mineral and bone disorder in chronic kidney disease (CKD-MBD). This serious condition affects most people as their kidney disease progresses.

Launch of the ADPKD Patient Routemap: an interactive new resource to help empower patients and families

[PRESSWIRE] Copenhagen, Denmark - 24 May, 2018 -- ERA-EDTA Congress 2018 sees the launch of the ADPKD Patient Route Map, an interactive resource designed to help educate and empower people affected by autosomal dominant polycystic kidney disease (ADPKD).

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

 [PRESSWIRE] PALO ALTO, California, May 18, 2018 -- ReCor Medical announced today that it will present the primary outcomes data from the SOLO study of its RADIANCE Global Clinical Trial Program of the Paradise® Ultrasound Renal Denervation System for patients with hypertension during the Late Breaker Sessions at the EuroPCR 2018 Meeting in Paris on 23 May.